|Tested species reactivity||Mouse|
|Published species reactivity||Not Applicable|
|Host / Isotype||Goat / IgG|
|Immunogen||Gamma Immunoglobins Heavy and Light chains|
|Storage buffer||50mM tris, pH 7.5, with 40% glycerol, 1% BSA|
|Contains||0.1% sodium azide|
|Storage Conditions||4° C|
|Antibody Form||Whole Antibody|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||Assay-Dependent|
|Western Blot (WB)||Assay-Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
ZyMAX antibodies are specifically isolated from antigen-affinity columns using advanced elution protocols, leaving only the highest affinity, antigen-specific antibodies. ZyMAX conjugates are prepared with modified cross-linkers to achieve optimal conjugation ratios and stability. Improved purification methods virtually eliminate unconjugated components, giving superior sensitivity and lowest possible levels of background.
Anti-Mouse secondary antibodies are affinity-purified antibodies with well-characterized specificity for mouse immunoglobulins and are useful in the detection, sorting or purification of its specified target. Secondary antibodies offer increased versatility enabling users to use many detection systems (e.g. HRP, AP, fluorescence). They can also provide greater sensitivity through signal amplification as multiple secondary antibodies can bind to a single primary antibody. Most commonly, secondary antibodies are generated by immunizing the host animal with a pooled population of immunoglobulins from the target species and can be further purified and modified (i.e. immunoaffinity chromatography, antibody fragmentation, label conjugation, etc.) to generate highly specific reagents.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis.
62-6522 was used in ELISA to determine how induced arthritis can be effectively treated by CTRP6
|Murayama MA,Kakuta S,Inoue A,Umeda N,Yonezawa T,Maruhashi T,Tateishi K,Ishigame H,Yabe R,Ikeda S,Seno A,Chi HH,Hashiguchi Y,Kurata R,Tada T,Kubo S,Sato N,Liu Y,Hattori M,Saijo S,Matsushita M,Fujita T,Sumida T,Iwakura Y||Nature communications (6:null)||2015|
A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA).
62-6522 was used in ELISA to discuss Neisseria meningitidis vaccines for people in sub-Saharan Africa
|Koeberling O,Ispasanie E,Hauser J,Rossi O,Pluschke G,Caugant DA,Saul A,MacLennan CA||Vaccine (32:2688)||2014|
TRPV4 regulates the integrity of the blood-cerebrospinal fluid barrier and modulates transepithelial protein transport.
62-6522 was used in western blot to examine the regulatory mechanism of blood-cerebrospinal fluid barrier
|Narita K,Sasamoto S,Koizumi S,Okazaki S,Nakamura H,Inoue T,Takeda S||FASEB journal : official publication of the Federation of American Societies for Experimental Biology (29:2247)||2015|
|Not Applicable||Not Cited||
Proteomic analysis of multiple primary cilia reveals a novel mode of ciliary development in mammals.
62-6522 was used in western blot to determine the proteome of choroid plexus epithelial cells
|Narita K,Kozuka-Hata H,Nonami Y,Ao-Kondo H,Suzuki T,Nakamura H,Yamakawa K,Oyama M,Inoue T,Takeda S||Biology open (1:815)||2012|
|Not Applicable||1 mg/ml||
Electrochemical detection of receptor-mediated endocytosis by scanning electrochemical microscopy.
62-6522 was used in immunocytochemistry to use a novel scanning electrochemical microscopy-based method to study epidermal growth factor receptor-mediated endocytosis
|Takahashi Y,Miyamoto T,Shiku H,Ino K,Yasukawa T,Asano R,Kumagai I,Matsue T||Physical chemistry chemical physics : PCCP (13:16569)||2011|